Masako Wakitani

2.4k total citations
15 papers, 1.8k citations indexed

About

Masako Wakitani is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Biotechnology. According to data from OpenAlex, Masako Wakitani has authored 15 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 15 papers in Radiology, Nuclear Medicine and Imaging and 3 papers in Biotechnology. Recurrent topics in Masako Wakitani's work include Monoclonal and Polyclonal Antibodies Research (15 papers), Glycosylation and Glycoproteins Research (11 papers) and Viral Infectious Diseases and Gene Expression in Insects (6 papers). Masako Wakitani is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (15 papers), Glycosylation and Glycoproteins Research (11 papers) and Viral Infectious Diseases and Gene Expression in Insects (6 papers). Masako Wakitani collaborates with scholars based in Japan and Singapore. Masako Wakitani's co-authors include Kenya Shitara, Mitsuo Satoh, Shigeru Iida, Kazuhisa Uchida, Rinpei Niwa, Naoko Yamane‐Ohnuki, Ryosuke Nakano, Kazuyasu Nakamura, Akito Natsume and Miho Inoue and has published in prestigious journals such as Journal of Molecular Biology, Cancer Research and Clinical Cancer Research.

In The Last Decade

Masako Wakitani

15 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Masako Wakitani Japan 14 1.5k 1.4k 696 219 204 15 1.8k
John B. Briggs United States 9 1.1k 0.7× 1.1k 0.8× 533 0.8× 191 0.9× 142 0.7× 12 1.6k
Rinpei Niwa Japan 19 1.6k 1.0× 1.7k 1.2× 864 1.2× 418 1.9× 217 1.1× 22 2.2k
Lori O'Connell United States 7 1.2k 0.8× 1.2k 0.8× 674 1.0× 150 0.7× 148 0.7× 7 1.8k
Naoko Yamane‐Ohnuki Japan 9 964 0.6× 851 0.6× 353 0.5× 134 0.6× 158 0.8× 9 1.1k
Royston Jefferis United Kingdom 17 1.2k 0.8× 1.2k 0.8× 520 0.7× 96 0.4× 128 0.6× 29 1.6k
Katsuhiro Mori Japan 10 886 0.6× 682 0.5× 324 0.5× 118 0.5× 114 0.6× 11 1.0k
Mitchell E. Reff United States 21 781 0.5× 555 0.4× 387 0.6× 159 0.7× 87 0.4× 41 1.2k
Yik A. Yeung United States 17 929 0.6× 954 0.7× 441 0.6× 328 1.5× 149 0.7× 23 1.4k
Mehmet Kemal Tur Germany 19 627 0.4× 388 0.3× 367 0.5× 267 1.2× 117 0.6× 43 1.1k
Gregory L. Moore United States 18 639 0.4× 649 0.5× 432 0.6× 318 1.5× 71 0.3× 42 1.2k

Countries citing papers authored by Masako Wakitani

Since Specialization
Citations

This map shows the geographic impact of Masako Wakitani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masako Wakitani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masako Wakitani more than expected).

Fields of papers citing papers by Masako Wakitani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masako Wakitani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masako Wakitani. The network helps show where Masako Wakitani may publish in the future.

Co-authorship network of co-authors of Masako Wakitani

This figure shows the co-authorship network connecting the top 25 collaborators of Masako Wakitani. A scholar is included among the top collaborators of Masako Wakitani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masako Wakitani. Masako Wakitani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Kobayashi, Y., Eiji Takahashi, Masako Wakitani, et al.. (2011). Fucose content of monoclonal antibodies can be controlled by culture medium osmolality for high antibody-dependent cellular cytotoxicity. Cytotechnology. 64(3). 249–265. 39 indexed citations
2.
Okazaki, Akira, et al.. (2009). A Chromatographic Approach for Elevating the Antibody-Dependent Cellular Cytotoxicity of Antibody Composites. Biological and Pharmaceutical Bulletin. 32(9). 1604–1608. 7 indexed citations
3.
Natsume, Akito, Hiroyuki Takamura, Tomoaki Nakagawa, et al.. (2008). Engineered Antibodies of IgG1/IgG3 Mixed Isotype with Enhanced Cytotoxic Activities. Cancer Research. 68(10). 3863–3872. 148 indexed citations
4.
Ando, Hiroshi, Masako Wakitani, Takashi Sato, et al.. (2008). Mouse-Human Chimeric Anti-Tn IgG1 Induced Anti-tumor Activity against Jurkat Cells in Vitro and in Vivo. Biological and Pharmaceutical Bulletin. 31(9). 1739–1744. 32 indexed citations
6.
Masuda, Kazuhiro, Tsuguo Kubota, Shigeru Iida, et al.. (2007). Enhanced binding affinity for FcγRIIIa of fucose-negative antibody is sufficient to induce maximal antibody-dependent cellular cytotoxicity. Molecular Immunology. 44(12). 3122–3131. 135 indexed citations
7.
Iida, Shigeru, Hirofumi Misaka, Miho Inoue, et al.. (2006). Nonfucosylated Therapeutic IgG1 Antibody Can Evade the Inhibitory Effect of Serum Immunoglobulin G on Antibody-Dependent Cellular Cytotoxicity through its High Binding to FcγRIIIa. Clinical Cancer Research. 12(9). 2879–2887. 174 indexed citations
9.
Kanda, Yutaka, Naoko Yamane‐Ohnuki, Naoto Sakai, et al.. (2006). Comparison of cell lines for stable production of fucose‐negative antibodies with enhanced ADCC. Biotechnology and Bioengineering. 94(4). 680–688. 90 indexed citations
10.
Kobayashi, Yukari, Masako Wakitani, Kazuhisa Uchida, et al.. (2006). Enhanced Fc-Dependent Cellular Cytotoxicity of Fc Fusion Proteins Derived from TNF Receptor II and LFA-3 by Fucose Removal from Asn-Linked Oligosaccharides. The Journal of Biochemistry. 140(6). 777–783. 28 indexed citations
11.
Natsume, Akito, Masako Wakitani, Naoko Yamane‐Ohnuki, et al.. (2005). Fucose removal from complex-type oligosaccharide enhances the antibody-dependent cellular cytotoxicity of single-gene-encoded antibody comprising a single-chain antibody linked the antibody constant region. Journal of Immunological Methods. 306(1-2). 93–103. 49 indexed citations
12.
Niwa, Rinpei, Akito Natsume, Masako Wakitani, et al.. (2005). IgG subclass-independent improvement of antibody-dependent cellular cytotoxicity by fucose removal from Asn297-linked oligosaccharides. Journal of Immunological Methods. 306(1-2). 151–160. 187 indexed citations
13.
Yamane‐Ohnuki, Naoko, Satoko Kinoshita, Shigeru Iida, et al.. (2004). Establishment of FUT8 knockout Chinese hamster ovary cells: An ideal host cell line for producing completely defucosylated antibodies with enhanced antibody‐dependent cellular cytotoxicity. Biotechnology and Bioengineering. 87(5). 614–622. 424 indexed citations
14.
Mori, Katsuhiro, Reiko Kuni‐Kamochi, Naoko Yamane‐Ohnuki, et al.. (2004). Engineering Chinese hamster ovary cells to maximize effector function of produced antibodies using FUT8 siRNA. Biotechnology and Bioengineering. 88(7). 901–908. 132 indexed citations
15.
Okazaki, Akira, Kazuyasu Nakamura, Masako Wakitani, et al.. (2004). Fucose Depletion from Human IgG1 Oligosaccharide Enhances Binding Enthalpy and Association Rate Between IgG1 and FcγRIIIa. Journal of Molecular Biology. 336(5). 1239–1249. 258 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026